Bone metastases are common in patients with advanced cancer. Bisphosphonates (BPs) could prevent or delay the development of skeleton-related events (SREs). The present study aimed to identify the clinical fea...
from Cancer via ola Kala on Inoreader http://ift.tt/1TtbMy0
via IFTTT
Δευτέρα 25 Απριλίου 2016
A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου